1993
Both aborted sudden cardiac death and end-stage phase in hypertrophic cardiomyopathy
Maron B, Hecht G, Klues H, Kunkes S, Rosenfeld L, Cecchi F. Both aborted sudden cardiac death and end-stage phase in hypertrophic cardiomyopathy. The American Journal Of Cardiology 1993, 72: 363-365. PMID: 8342522, DOI: 10.1016/0002-9149(93)90690-e.Peer-Reviewed Original ResearchMeSH KeywordsAdultCardiomyopathy, HypertrophicCardiopulmonary ResuscitationDeath, Sudden, CardiacFemaleHumansMaleTime FactorsConceptsSudden cardiac deathEnd-stage phaseCardiac deathHypertrophic cardiomyopathyLeft ventricular wall thinningNatural historyUnique clinical courseVentricular wall thinningDiverse natural historyClinical courseImpaired contractilityPatientsCavity enlargementCardiomyopathyPresent reportGenetic substrateDeath
1992
Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study
Sager P, Perlmutter R, Rosenfeld L, Batsford W. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study. American Heart Journal 1992, 123: 926-933. PMID: 1550002, DOI: 10.1016/0002-8703(92)90698-u.Peer-Reviewed Original ResearchConceptsTest-negative groupInducible ventricular tachycardiaTest positive groupVentricular tachycardiaElectrophysiologic studyVentricular arrhythmiasClinical characteristicsSignificant organic heart diseaseInducible sustained ventricular tachycardiaDrug-induced exacerbationGroups' clinical characteristicsInducible ventricular arrhythmiasDrug testsVentricular ejection fractionVentricular tachycardia inductionOrganic heart diseaseSustained ventricular tachycardiaBundle branch blockDrug-free stateVentricular tachycardia inducibilityTachycardia inductionAntiarrhythmic therapyInducible arrhythmiasEjection fractionVentricular aneurysm